Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by apainteron Jul 14, 2014 1:20pm

233 Views

Post# 22743250

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Earnings

Yes, that is one of the expenses but there are other expenses too.

But what I am trying to understand is that the company's main focus is the product AGGRASTAT and there are SG &A expenses associated in the amt of 1.149M for the nine months but I am not sure what the other SG&A expense of 1.142M for nine months is for which is almost equal to their main product.
I would really appreciate some clarification from other members more knowledgeable than me

Thanks

apainter

Bullboard Posts

The top 10 artificial intelligence penny stocks